• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Dhansa Labs Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
92828
INE0M3I01029
35.4982409
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DHANSA
9.02
51.76
EPS(TTM)
Face Value()
Div & Yield %
2.3
10
0
 

KIMS inks long term lease deal to establish multi-speciality hospital in Amaravati
May 11,2026
The agreement covers 2 acres of land in Amravati. The proposed multi-speciality hospital will offer comprehensive tertiary and quaternary care across cardiology, oncology, neurosciences, gastroenterology, orthopaedics, mother & child care, critical care, organ transplant and other key specialties, addressing a long-standing need for advanced healthcare infrastructure in the region.

Once operational, patients in Amaravati and surrounding districts of Andhra Pradesh will gain access to high-end clinical capabilities, reducing the need of travel to other metros for specialised care.

Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.

The company’s consolidated net profit declined 39.8% to Rs 53.40 crore despite of 29.2% increase in revenue from operations to Rs 997.70 crore in Q3 FY26 over Q3 FY25.

The counter advanced 1.41% to end at Rs 717.55 on the BSE.